Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKLINASDAQ:AVRNYSE:INFUNASDAQ:KRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKLIAkili$0.43$0.43$0.19▼$1.25$34.01M1.722.20 million shsN/AAVRAnteris Technologies Global$3.64+12.7%$3.96$2.34▼$8.79$131.27MN/A204,872 shs191,576 shsINFUInfuSystem$5.41-6.7%$5.30$4.61▼$9.97$113.70M1.7393,988 shs175,434 shsKRMDKORU Medical Systems$2.66-2.2%$2.63$1.86▼$5.05$125.50M0.39139,563 shs99,323 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKLIAkili0.00%0.00%0.00%0.00%+2.86%AVRAnteris Technologies Global+12.69%-12.29%-18.75%-55.88%+363,999,900.00%INFUInfuSystem-6.72%-12.03%+8.20%-29.28%-27.96%KRMDKORU Medical Systems-2.21%-9.83%+9.92%-28.30%+19.28%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKLIAkiliN/AN/AN/AN/AN/AN/AN/AN/AAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/AINFUInfuSystem2.454 of 5 stars2.00.00.00.03.04.21.9KRMDKORU Medical Systems2.1914 of 5 stars3.53.00.00.00.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKLIAkili 0.00N/AN/AN/AAVRAnteris Technologies Global 3.00Buy$16.50353.30% UpsideINFUInfuSystem 4.00Strong Buy$13.00140.30% UpsideKRMDKORU Medical Systems 3.00Buy$4.5069.17% UpsideCurrent Analyst Ratings BreakdownLatest AKLI, KRMD, AVR, and INFU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025INFUInfuSystemB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.503/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/13/2025KRMDKORU Medical SystemsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKLIAkili$1.95M17.46N/AN/A$0.75 per share0.58AVRAnteris Technologies Global$2.71M48.42N/AN/AN/A∞INFUInfuSystem$137.58M0.83$0.42 per share12.79$2.47 per share2.19KRMDKORU Medical Systems$35.08M3.50N/AN/A$0.45 per share5.91Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKLIAkili-$59.49M-$0.61N/AN/AN/A-2,492.04%-79.93%-59.16%N/AAVRAnteris Technologies GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/AINFUInfuSystem$870K$0.1490.1817.45N/A1.12%2.78%1.41%N/AKRMDKORU Medical Systems-$13.74M-$0.11N/AN/AN/A-37.42%-24.60%-16.87%8/6/2025 (Estimated)Latest AKLI, KRMD, AVR, and INFU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKLIAkiliN/AN/AN/AN/AN/AAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKLIAkili0.085.805.80AVRAnteris Technologies GlobalN/AN/AN/AINFUInfuSystem0.501.981.59KRMDKORU Medical Systems0.012.992.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKLIAkili53.12%AVRAnteris Technologies GlobalN/AINFUInfuSystem71.13%KRMDKORU Medical Systems58.60%Insider OwnershipCompanyInsider OwnershipAKLIAkili10.10%AVRAnteris Technologies GlobalN/AINFUInfuSystem11.40%KRMDKORU Medical Systems20.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKLIAkili13078.73 million70.78 millionOptionableAVRAnteris Technologies Global13836.06 millionN/AN/AINFUInfuSystem41021.02 million19.10 millionOptionableKRMDKORU Medical Systems8046.14 million34.10 millionOptionableAKLI, KRMD, AVR, and INFU HeadlinesRecent News About These CompaniesKORU Medical Systems holds annual shareholder meetingMay 17, 2025 | uk.investing.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comHere's What Analysts Are Forecasting For KORU Medical Systems, Inc. (NASDAQ:KRMD) After Its First-Quarter ResultsMay 10, 2025 | finance.yahoo.comKORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comKORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue GuidanceMay 7, 2025 | businesswire.comBoothbay Fund Management LLC Decreases Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)May 7, 2025 | marketbeat.com683 Capital Management LLC Invests $340,000 in KORU Medical Systems, Inc. (NASDAQ:KRMD)May 5, 2025 | marketbeat.com272 Capital LP Lowers Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)May 4, 2025 | marketbeat.comKORU Medical Systems (KRMD) Expected to Announce Quarterly Earnings on WednesdayMay 2, 2025 | marketbeat.comEven after rising 14% this past week, KORU Medical Systems (NASDAQ:KRMD) shareholders are still down 75% over the past five yearsMay 1, 2025 | uk.finance.yahoo.comFirst Light Asset Management LLC Grows Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)April 30, 2025 | marketbeat.comTopline Capital Management LLC Purchases Shares of 4,327,164 KORU Medical Systems, Inc. (NASDAQ:KRMD)April 27, 2025 | marketbeat.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 5.80%April 23, 2025 | aaii.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 7.49%April 21, 2025 | aaii.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Down 9.22%April 10, 2025 | aaii.comKoru Medical management to meet with Craig-HallumApril 9, 2025 | markets.businessinsider.comKORU Medical Systems, Inc.'s (NASDAQ:KRMD) market cap dropped US$17m last week; individual investors who hold 43% were hit as were institutionsMarch 20, 2025 | finance.yahoo.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comKoru Medical reports Q4 EPS (13c), consensus (2c)March 12, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAKLI, KRMD, AVR, and INFU Company DescriptionsAkili NASDAQ:AKLIAkili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.Anteris Technologies Global NASDAQ:AVR$3.64 +0.41 (+12.69%) As of 05/23/2025 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.InfuSystem NYSE:INFU$5.41 -0.39 (-6.72%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$5.44 +0.03 (+0.55%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.KORU Medical Systems NASDAQ:KRMD$2.66 -0.06 (-2.21%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.65 -0.01 (-0.38%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
